Clinically Relevant Effect of UGT1A4*3 on Lamotrigine Serum Concentration Is Restricted to Postmenopausal Women—A Study Matching Therapeutic Drug Monitoring and Genotype Data From 534 Patients-Reference-Cited by-同舟云学术

Clinically Relevant Effect of UGT1A4*3 on Lamotrigine Serum Concentration Is Restricted to Postmenopausal Women—A Study Matching Therapeutic Drug Monitoring and Genotype Data From 534 Patients

Published:2018-10 Issue:5 Volume:40 Page:567-571
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Smith Robert L.,Haslemo Tore,Chan Hilde F.,Refsum Helge,Molden Espen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference18 articles.

1. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?;Johannessen;Clin Pharmacokinet.,2006

2. A pharmacogenetics study of the human glucuronosyltransferase UGT1A4;Benoit-Biancamano;Pharmacogenet Genomics.,2009

3. Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4;Ehmer;Hepatology.,2004

4. Olanzapine metabolism and the significance of UGT1A448V and UGT2B1067Y variants;Erickson-Ridout;Pharmacogenet Genomics.,2011

5. UGT1A4*3 encodes significantly increased glucuronidation of olanzapine in patients on maintenance treatment and in recombinant systems;Haslemo;Clin Pharmacol Ther.,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs;JAMA Network Open;2024-08-08

2. UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in Giredestrant Exposure;Cancer Chemotherapy and Pharmacology;2024-02-02

3. Current Status of Therapeutic Drug Monitoring in Mental Health Treatment: A Review;Pharmaceutics;2022-12-01

4. Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects;Expert Opinion on Drug Metabolism & Toxicology;2020-02-13

5. Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation;Drug Metabolism and Disposition;2019-11-14